Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences, Inc.    GILD

GILEAD SCIENCES, INC.

(GILD)
  Report
Delayed Quote. Delayed Nasdaq - 10/30 04:00:00 pm
58.15 USD   -0.65%
10/29GLOBAL MARKETS LIVE: Big names today
10/29GILEAD SCIENCES : Announces Fourth Quarter 2020 Dividend
AQ
10/29GILEAD SCIENCES : Announces Third Quarter 2020 Financial Results
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on GILEAD SCIENCES, INC.
02/09/21 Jahr 2020 Ergebnisveröffentlichung (geplant)
05/06/21 Q1 2021 Ergebnisveröffentlichung (geplant)
08/03/21 Erstes Halbjahr 2021 Ergebnisveröffentlichung (geplant)
11/02/21 Q3 2021 Ergebnisveröffentlichung (geplant)
Past events on GILEAD SCIENCES, INC.
10/30/20 BioNJ C-Suite Summit
10/28/20 | 09:30pm Q3 2020 Präsentation des Ergebnisses
10/28/20 Q3 2020 Ergebnisveröffentlichung
10/21/20 IDWeek Virtual Conference - Poster No - 995
Upcoming sector events for GILEAD SCIENCES, INC.
10/31/20 HUALAN BIOLOGICAL ENGINEERING INC. : Q3 2020 Earnings Release
11/02/20 ICON PUBLIC LIMITED COMPANY : World Orphan Drug Europe Congress
11/02/20 | 06:20pm IOVANCE BIOTHERAPEUTICS, INC. : Next Generation CAR and T Cell Therapies Conference
11/03/20 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. : A3P Microbiology Conference
More events
Past sector events for GILEAD SCIENCES, INC.
10/30/20 MODERNA, INC. : BioNJ C-Suite Summit
10/29/20 | 04:30pm VERTEX PHARMACEUTICALS INCORPORATED : Q3 2020 Earnings Call
10/29/20 | 09:30am CHARLES RIVER LABORATORIES INTERNATIONAL, INC. : Q3 2020 Earnings Call
10/29/20 | 08:30am BLUEPRINT MEDICINES CORPORATION : Q3 2020 Earnings Call
Annual publications
Annual results201520162017201820192020 (e)
Sales
M $
Released
Forecast
Spread
32 639
32 303
1,0%
30 390
30 236
0,51%
26 107
25 842
1,0%
22 127
21 839
1,3%
22 449
22 305
0,65%

23 690
Operating income
(EBITDA)
M $
Released
Forecast
Spread
23 557
23 693
-0,58%
21 191
20 987
0,97%
17 317
16 841
2,8%
12 840
12 564
2,2%
12 468
13 029
-4,3%

12 756
Operating profit
(EBIT)
M $
Released
Forecast
Spread
23 396
22 981
1,8%
20 033
20 018
0,07%
16 031
16 041
-0,06%
11 411
11 753
-2,9%
11 064
11 571
-4,4%

11 235
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
21 659
21 429
1,1%
17 097
17 169
-0,42%
13 529
13 843
-2,3%
7 799
9 060
-14%
5 160
5 333
-3,2%

2 000
Net income
M $
Released
Forecast
Spread
18 108
17 741
2,1%
13 501
13 570
-0,51%
4 628
10 263
-55%
5 455
7 207
-24%
5 386
4 292
26%

424
EPS
$
Released
Forecast
Spread
11,9
11,5
3,5%
9,94
10,1
-1,9%
3,51
7,71
-54%
4,17
5,47
-24%
4,22
3,43
23%

0,54
Announcement Date02/02/201602/07/201702/06/201802/04/201902/04/2020

Quarterly publications
Previous periodNext period
Quarterly results2019 Q22019 Q32019 Q42020 Q12020 Q22020 Q3 (e)
Sales
M $
Released
Forecast
Spread
5 685
5 542
2,6%
5 604
5 613
-0,17%
5 879
5 736
2,5%
5 548
5 439
2,0%
5 143
5 303
-3,0%

6 303
Operating income
(EBITDA)
M $
Released
Forecast
Spread
3 388
3 296
2,8%
3 271
3 307
-1,1%
2 662
3 270
-19%
3 114
3 035
2,6%
2 344
2 755
-15%

3 688
Operating profit
(EBIT)
M $
Released
Forecast
Spread
3 040
2 926
3,9%
2 924
2 910
0,50%
2 312
2 820
-18%
2 765
2 619
5,6%
1 995
2 375
-16%

3 132
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
2 410
2 145
12%
-1 501
-1 676
10%
1 901
2 080
-8,6%
2 003
2 129
-5,9%
-2 973
-3 101
4,1%

1 844
Net income
M $
Released
Forecast
Spread
1 880
1 694
11%
-1 165
-1 701
31%
2 696
1 596
69%
1 551
1 619
-4,2%
-3 339
-1 570
-113%

1 577
EPS
$
Released
Forecast
Spread
1,47
1,31
12%
-0,92
-0,66
-40%
2,12
1,22
74%
1,22
1,25
-2,5%
-2,66
-0,88
-204%

1,25
Announcement Date07/30/201910/24/201902/04/202004/30/202007/30/2020

Financial data source
© 2020 S&P Global Market Intelligence
© 2020 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise